# Efficacy of Oral Apremilast in the Treatment of Alopecia Areata at the Tertiary Care Hospital, Karachi.

> **NCT05926882** · PHASE4 · COMPLETED · sponsor: **Jinnah Postgraduate Medical Centre** · enrollment: 30 (actual)

## Conditions studied

- Alopecia Areata

## Interventions

- **DRUG:** Apremilast 30mg

## Key facts

- **NCT ID:** NCT05926882
- **Lead sponsor:** Jinnah Postgraduate Medical Centre
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-01
- **Primary completion:** 2023-06-20
- **Final completion:** 2023-06-20
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05926882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05926882, "Efficacy of Oral Apremilast in the Treatment of Alopecia Areata at the Tertiary Care Hospital, Karachi.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05926882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*